TACTOGEN

tactogen-logo

Tactogen is a biopharma startup that develops empathogen medicines. The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus on one goal: enabling safer take-home prescription empathogens. It is headquartered in Palo Alto, California in 2020 by Ph.D. neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky.

#SimilarOrganizations #People #Financial #Website #More

TACTOGEN

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2020-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.tactogen.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
CrUX Dataset CrUX Top 50m


Similar Organizations

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

zarina-sciences-logo

Zarina Sciences

Lab Supplies & Emergencies

Current Employees Featured

matthew-baggott-phd_image

Matthew Baggott, Ph.D.
Matthew Baggott, Ph.D. Co-Founder and CEO @ Tactogen
Co-Founder and CEO
2019-12-01

Founder


matthew-baggott-phd_image

Matthew Baggott, Ph.D.

Investors List

psychedelic-medicine-syndicate_image

PsyMed Ventures

PsyMed Ventures investment in Seed Round - Tactogen

noetic-fund_image

Noetic Fund

Noetic Fund investment in Seed Round - Tactogen

lionheart-ventures_image

Lionheart Ventures

Lionheart Ventures investment in Pre Seed Round - Tactogen

10x-capital_image

10X Capital

10X Capital investment in Pre Seed Round - Tactogen

Official Site Inspections

http://www.tactogen.com Semrush global rank: 7.24 M Semrush visits lastest month: 846

  • Host name: 173.231.192.10
  • IP address: 173.231.192.10
  • Location: El Segundo United States
  • Latitude: 33.9214
  • Longitude: -118.413
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90245

Loading ...

More informations about "Tactogen"

Tactogen - Crunchbase Company Profile & Funding

Tactogen has 4 investors including PsyMed Ventures and Noetic Fund. When was the last funding round for Tactogen? Tactogen closed its last funding round on Jan 1, 2022 from a Seed round. Who are Tactogen 's competitors? โ€ฆSee details»

TACTOGEN Company Profile | Management and Employees List

For Everyone.Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew โ€ฆSee details»

Tactogen Inc โ€“ Vision

Our values โ€” community, cooperation, transparency, and scientific integrity โ€” emerge from our goals.See details»

Tactogen Inc Company Profile | Menlo Park, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Tactogen Inc of Menlo Park, CA. Get the latest business insights from Dun & Bradstreet.See details»

Tactogen Company Profile 2024: Valuation, Funding & Investors

Tactogen General Information Description. Operator of a research-driven pharma tech company intended to make medicines safer, more effective, and more accessible. The company โ€ฆSee details»

Tactogen: Developing new MDMA-like medicines for effective โ€ฆ

The offering materials may contain forward-looking statements and information relating to, among other things, Tactogen Inc (hereby referred to as Tactogen), its business plan and strategy, โ€ฆSee details»

Tactogen - The Org

Tactogen is a biopharma startup that develops empathogen medicines.The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus โ€ฆSee details»

Tactogen Overview | SignalHire Company Profile

Tactogen is a biopharma startup that develops empathogen medicines.\n\nThe startup company offers drug discovery methods, novel molecules, ... Organization Website: tactogen.com : โ€ฆSee details»

Tactogen - Contacts, Employees, Board Members, Advisors & Alumni

Tactogen has 1 current employee profile, Co-Founder and CEO Matthew Baggott, Ph.D.. Matthew Baggott, Ph.D. Co-Founder and CEO Unlock even more features with Crunchbase ProSee details»

Tactogen: Contact Details and Business Profile - RocketReach

For Everyone. Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew โ€ฆSee details»

Tactogen - LinkedIn

Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Tactogen | 1,452 followers on LinkedIn. Effective prescription mental wellness.See details»

Tactogen Inc โ€“ Pipeline

Tactogen is a mission-based and research-driven pharmatech company that uses machine learning and targeted assays to identify promising new medicines and new treatments. We โ€ฆSee details»

TACTOGEN - Overview, News & Similar companies | ZoomInfo.com

Jan 13, 2023 For Everyone. Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist โ€ฆSee details»

Tactogen - VentureRadar

At Tactogen, we are developing a next generation of mental wellness medicines. Psychedelics and other transformative medicines have great promise to heal souls and change lives. โ€ฆSee details»

Tactogen: Revenue, Competitors, Alternatives - growjo.com

For Everyone. Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew โ€ฆSee details»

Tactogen - Blossom Profile

In April 2021, Tactogen raised U$1.5 million through early-stage venture capital. The company has indicated that itโ€™s a public benefit corporation. โ€œWe are a public benefit corporation. We โ€ฆSee details»

Why I invested in Tactogen - Medium

Tactogen raised $92,542 from 158 investors on WeFunder. My investment was $1,000. (Investing in startups is risky. No one should invest more than they can afford to lose.)See details»

Tactogen Inc โ€“ News

Tactogen has been studying 5-MeO-MiPT because, in low doses, it has non-psychedelic effects that are reminiscent of the drug MDMA, which is a promising treatment for PTSD (e.g., Mitchell โ€ฆSee details»

Tactogen: Developing new MDMA-like medicines for effective โ€ฆ

Tactogen has a deep appreciation for the role of community and connection in healing and wellness. If successful, Tactogen could support healing in many people and improve health โ€ฆSee details»

linkstock.net © 2022. All rights reserved